U.S. stocks traded lower toward the end of trading, with the Dow Jones dropping over 400 points on Wednesday.
The Dow traded down 1.32% to 31,732.39 while the NASDAQ fell 0.24% to 11,400.70. The S&P 500, also fell, dropping, 1.11% to 3,875.80.
Gainers
ThermoGenesis Holdings, Inc. (NASDAQ: THMO) shares jumped 80% to $3.7820 after the company announced the roll out of ReadyStart cGMP Suites for early-stage cell and gene-therapy companies.
U.S. stocks traded lower this morning, with the Dow Jones dropping more than 500 points on Wednesday.
Following the market opening Wednesday, the Dow traded down 1.69% to 31,612.42 while the NASDAQ fell 1.26% to 11,284.65. The S&P 500, also fell, dropping, 1.64% to 3,855.15.
ThermoGenesis Holdings, Inc. (Nasdaq: THMO), a market leader in automated cell processing tools and services in the cell and gene therapy field, today announced that the Company is rolling out a new